Source: Eur Respir Rev, 29 (158) 200001; 10.1183/16000617.0001-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Salvatore Cazzato, Alessia Omenetti, Claudia Ravaglia, Venerino Poletti. Lung involvement in monogenic interferonopathies. Eur Respir Rev, 29 (158) 200001; 10.1183/16000617.0001-2020

Member's Comments

No comment yet.

Related content which might interest you: Lung involvement in autoimmune liver diseases Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Lung function in Birt-Hogg-Dubé syndrome Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Lung pathology in COVID-19 Source: Eur Respir Monogr 2021; 94: 86-100 Year: 2021 Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer Source: International Congress 2016 – IPF pathogenesis Year: 2016 Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema? Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Management of suspected monogenic lung fibrosis in a specialised centre Source: Eur Respir Rev, 26 (144) 160122; 10.1183/16000617.0122-2016 Year: 2017 Lung cancer and paraneoplastic syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 Lung Embryology, congenital abnormalities Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Pregnancy course in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Verification of genetic associations with Scleroderma associated Interstitial Lung Disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Aetiological panorama in the diagnosis of interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Lung cancer and associated diseases Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 Lung function decline in patients with severe alpha1-antitrypsin deficiency Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary? Source: International Congress 2014 – ILDs 4 Year: 2014